Cedric Francois
CEO
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Apellis Pharmaceuticals, Inc. (APLS) | M.D., Ph.D. President & Chief Executive Officer | $793,193 | $10,957,451 |
| 2023 | Apellis Pharmaceuticals, Inc. (APLS) | M.D., Ph.D. President & Chief Executive Officer | $734,539 | $10,373,049 |
| 2022 | Apellis Pharmaceuticals, Inc. (APLS) | M.D., Ph.D. President & Chief Executive Officer | $680,827 | $9,203,556 |
| 2021 | Apellis Pharmaceuticals, Inc. (APLS) | M.D., Ph.D. President & Chief Executive Officer | $647,115 | $9,122,039 |
| 2020 | Apellis Pharmaceuticals, Inc. (APLS) | M.D., Ph.D. President & Chief Executive Officer | $618,769 | $9,275,425 |
| 2019 | Apellis Pharmaceuticals, Inc. (APLS) | M.D., Ph.D. President & Chief Executive Officer | $560,019 | $4,267,182 |
| 2018 | Apellis Pharmaceuticals, Inc. (APLS) | M.D., Ph.D. President & Chief Executive Officer | $550,000 | $4,074,540 |
| 2017 | Apellis Pharmaceuticals, Inc. (APLS) | M.D., Ph.D. President & Chief Executive Officer | $400,000 | $1,662,972 |
Earnings-call appearances
-
Apellis Pharmaceuticals, Inc. Q4 FY2025 Earnings Call2026-01-12
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q3 FY2025 Earnings Call2025-09-30
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q2 FY2025 Earnings Call2025-06-30
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q1 FY2025 Earnings Call2025-03-31
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q4 FY2024 Earnings Call2025-01-13
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q3 FY2024 Earnings Call2024-09-30
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q2 FY2024 Earnings Call2024-06-30
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q1 FY2024 Earnings Call2024-03-31
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q4 FY2023 Earnings Call2024-01-08
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q3 FY2023 Earnings Call2023-10-05
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q2 FY2023 Earnings Call2023-07-31
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q1 FY2023 Earnings Call2023-03-31
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q3 FY2022 Earnings Call2022-09-30
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q2 FY2022 Earnings Call2022-06-30
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q1 FY2022 Earnings Call2022-03-31
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q4 FY2021 Earnings Call2022-01-10
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q3 FY2021 Earnings Call2021-09-30
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q2 FY2021 Earnings Call2021-06-30
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q1 FY2021 Earnings Call2021-03-31
Apellis Pharmaceuticals, Inc. (APLS)
-
Apellis Pharmaceuticals, Inc. Q4 FY2020 Earnings Call2020-12-31
Apellis Pharmaceuticals, Inc. (APLS)